| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 5,857,000 | 5,054,000 | 6,861,000 | 5,453,000 | | Cost of Revenue | 1,096,000 | 1,008,000 | 1,179,000 | 1,111,000 | | | Gross Profit | 4,761,000 | 4,046,000 | 5,682,000 | 4,342,000 | | | Operating Expenses | | Research Development | 708,000 | 660,000 | 730,000 | 677,000 | | Selling General and Administrative | 1,309,000 | 1,167,000 | 1,540,000 | 1,181,000 | | Non Recurring | 130,000 | 48,000 | 90,000 | 107,000 | | Others | 436,000 | 431,000 | 437,000 | 437,000 | | | | Total Operating Expenses | 2,583,000 | 2,306,000 | 2,797,000 | 2,402,000 | | | | Operating Income or Loss | 2,178,000 | 1,740,000 | 2,885,000 | 1,940,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34,000 | 1,000 | 29,000 | (11,000) | | Earnings Before Interest And Taxes | 2,212,000 | 1,741,000 | 2,914,000 | 1,964,000 | | Interest Expense | 189,000 | 179,000 | 159,000 | 154,000 | | Income Before Tax | 2,023,000 | 1,562,000 | 2,755,000 | 1,810,000 | | Income Tax Expense | 565,000 | 438,000 | 864,000 | 481,000 | | Minority Interest |
-
|
-
|
-
| 35,000 | | | | Net Income From Continuing Ops | 1,458,000 | 1,124,000 | 1,891,000 | 1,329,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,458,000 | 1,124,000 | 1,891,000 | 1,329,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,458,000 | $1,124,000 | $1,891,000 | $1,329,000 |
|
1.52% Nasdaq 
Income Statement
